Buprenorphine–naloxone

CMAJ - Canada
doi 10.1503/cmaj.180776
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Abuse Liability of Intravenous Buprenorphine/Naloxone and Buprenorphine Alone in Buprenorphine-Maintained Intravenous Heroin Abusers

Addiction
MedicinePsychiatryMental Health
2010English

Buprenorphine/Naloxone Maintenance Therapy in Patients With Meperidine Use Disorder

International Journal of Basic & Clinical Pharmacology
2017English

Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?

Substance Use and Misuse
Mental HealthEnvironmentalPublic HealthPsychiatryHealthMedicineOccupational Health
2016English

Predictors of Relapse in Patients With Opioid Addiction During Buprenorphine–Naloxone Maintenance Treatment

Addiction & Addictive Disorders
2015English

Estimation of the Effect of Buprenorphine/Naloxone Dosing in Medicaid Opioid-Dependent Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Therapy Without a Prescription: Buprenorphine/Naloxone Diversion and the Therapeutic Assemblage in Taiwan

Sociology of Health and Illness
Health PolicyPublic HealthOccupational HealthHealthEnvironmental
2019English

New Developments in the Management of Opioid Dependence: Focus on Sublingual Buprenorphine–naloxone

Substance Abuse and Rehabilitation
2015English

Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy